Tag: survodutide
Weekly Dual-Hormone Injection Reduces Liver Fat by 67% in Obesity Trial
Phase 3 trial shows weekly survodutide injections reduced liver fat by 67% and achieved 18.5% weight loss in adults with…
Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial
Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in over 3,400 adults with obesity.…
Submit Your Paper to GMJ
No APC until January 2027.

